{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:24:24Z","timestamp":1780590264747,"version":"3.54.1"},"reference-count":37,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Neutropenic patients with acute myeloid leukemia (AML) are at high risk for severe, multidrug-resistant infections. Sepsis due to carbapenem-resistant Pseudomonas aeruginosa (CRPA) in this population often leads to septic shock and acute respiratory distress syndrome (ARDS), with historically poor outcomes. CytoSorb\u2122 hemoadsorption has been proposed as an adjunctive therapy for refractory septic shock, but evidence in hematologic malignancies remains limited. This report describes a 29-year-old male with newly diagnosed AML complicated by neutropenic fever, bacteremia due to CRPA, and subsequent hospital-acquired pneumonia progressing to ARDS. Despite multiple antibiotic regimens and aggressive intensive care management, including mechanical ventilation, prone positioning, and continuous renal replacement therapy (CRRT), the patient developed refractory septic shock with persistent lactic acidosis and elevated inflammatory markers. Early adjunctive CytoSorb hemoadsorption was initiated, guided by maximal CytoScore criteria, as part of a comprehensive supportive strategy. Following CytoSorb therapy, the patient demonstrated transient hemodynamic and biochemical improvement; however, profound neutropenia and multi-organ failure persisted. Microbiological clearance of CRPA was not achieved; given confirmed colistin susceptibility and unknown carbapenemase mechanism, a salvage combination of colistin plus ceftazidime\u2013avibactam was employed. Transient hemodynamic improvement was observed after CytoSorb initiation; however, cytokine assays were not performed, and microbiological clearance was not achieved, precluding any mechanistic attribution to CytoSorb. This case highlights the complexity of managing CRPA sepsis and ARDS in neutropenic AML patients, and the challenges in attributing observed clinical improvement to CytoSorb therapy in the context of multiple simultaneous interventions. The absence of cytokine assays (e.g., IL-6, TNF-\u03b1) precludes any mechanistic attribution of observed changes to cytokine adsorption, and interpretation should remain descriptive rather than causal. Observed transient changes occurred amid simultaneous interventions (broad-spectrum antibiotics, CRRT, prone ventilation, corticosteroids, and filgrastim), precluding attribution to any single therapy, including CytoSorb. Given the fatal outcome and persistent CRPA positivity, the clinical impact of this observation is limited, and the generalizability of a single-case report is restricted. Cautious interpretation is warranted, and CytoSorb may be considered as part of a comprehensive care bundle rather than as a standalone solution. Alternative tetracycline-based combinations were reviewed but not adopted under our center\u2019s salvage protocol for this XDR presentation. Future studies are warranted to clarify its clinical benefit and optimal timing in this population.<\/jats:p>","DOI":"10.3390\/diseases13120382","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:47:22Z","timestamp":1763984842000},"page":"382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early CytoSorb Hemoadsorption in a Neutropenic Acute Myeloid Leukemia Patient with Carbapenem-Resistant Pseudomonas Septic Shock and ARDS"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8179-0486","authenticated-orcid":false,"given":"Wei-Hung","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, MacKay Memorial Hospital, Taipei 10449, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-3808","authenticated-orcid":false,"given":"Ting-Yu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, MacKay Memorial Hospital, Taipei 10449, Taiwan"},{"name":"Department of Medicine, Mackay Medical College, New Taipei City 25245, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Kuo","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, MacKay Memorial Hospital, Taipei 10449, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"ref_1","first-page":"217","article-title":"Cytokine hemoadsorption with CytoSorb\u00ae in patients with sepsis: A systematic review and meta-analysis","volume":"35","year":"2023","journal-title":"Crit. Care Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/aas.14115","article-title":"Mortality and adverse events of hemoadsorption with CytoSorb\u00ae in critically ill patients: A systematic review and meta-analysis of randomized controlled trials","volume":"66","author":"Heymann","year":"2022","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12931-024-02675-8","article-title":"Hemoadsorption in acute respiratory distress syndrome patients requiring venovenous ECMO: A systematic review","volume":"25","author":"Li","year":"2024","journal-title":"Respir. Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sch\u00e4dler, D., Pausch, C., Heise, D., Meier-Hellmann, A., Brederlau, J., Weiler, N., Spies, C., Putensen, C., Gr\u00fcndling, M., and Petros, S. (2017). The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187015"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcrc.2018.11.003","article-title":"Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study","volume":"49","author":"Hawchar","year":"2019","journal-title":"J. Crit. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jcrc.2021.04.011","article-title":"High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock: A retrospective cohort study","volume":"64","author":"Schultz","year":"2021","journal-title":"J. Crit. Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13054-017-1662-9","article-title":"Hemoadsorption by CytoSorb in septic patients: A case series","volume":"21","author":"Kogelmann","year":"2017","journal-title":"Crit. Care"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rugg, C., Klose, R., Bachler, M., Koegerl, M., Schmid, A., Staudinger, T., Boesing, N., Lahmer, T., Huber, W., and Schmid, B. (2020). Advanced extracorporeal cytokine removal may improve survival of patients with septic shock: A propensity score analysis. Biomedicines, 8.","DOI":"10.3390\/biomedicines8120539"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","article-title":"Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology","volume":"98","author":"Kochanek","year":"2019","journal-title":"Ann. Hematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2023021414","article-title":"How I manage acute respiratory failure in patients with hematological malignancies","volume":"143","author":"Azoulay","year":"2024","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1186\/cc8149","article-title":"Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies","volume":"13","author":"Rhee","year":"2009","journal-title":"Crit. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00432-015-1955-9","article-title":"AML versus ICU: Outcome of septic AML patients in an intensive care setting","volume":"141","author":"Sippel","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13613-023-01172-3","article-title":"Characteristics and outcomes of patients with acute myeloid leukemia admitted to ICU with acute respiratory failure: A post-hoc analysis of a prospective multicenter study","volume":"13","author":"Secreto","year":"2023","journal-title":"Ann. Intensive Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/QCO.0000000000001044","article-title":"Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: Tailoring antibiotic therapy based on resistance mechanisms","volume":"37","author":"Falcone","year":"2024","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Vidal-Cort\u00e9s, P., Campos-Fern\u00e1ndez, S., Cuenca-Fito, E., Perez-Panero, E., Cores, M., Lage, E., Hern\u00e1ndez, M., Gir\u00e1ldez, A., Del Castillo, S., and Rodr\u00edguez-L\u00f3pez, M. (2025). Difficult-to-Treat Pseudomonas aeruginosa infections in critically ill patients: A comprehensive review and treatment proposal. Antibiotics, 14.","DOI":"10.3390\/antibiotics14020178"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cid\/ciac268","article-title":"IDSA 2022 Guidance on the treatment of extended-spectrum \u03b2-lactamase producing Enterobacterales, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201703-0548ST","article-title":"An Official ATS\/ESICM\/SCCM Clinical Practice Guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome","volume":"195","author":"Fan","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13613-019-0540-9","article-title":"Formal guidelines: Management of acute respiratory distress syndrome","volume":"9","author":"Papazian","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome (EOLIA Trial)","volume":"378","author":"Combes","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Almangour, T.A., Alkherb, Z., Ghonem, L., Albekairy, A., Alshehri, S., Alghamdi, S., Alshahrani, M., Alqahtani, S., Alsulaiman, T., and Alarfaj, A. (2025). Ceftazidime-avibactam versus colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections: A multicenter cohort study. Pharmaceuticals, 18.","DOI":"10.3390\/ph18010108"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jarczak, D., Kluge, S., and Nierhaus, A. (2021). Sepsis\u2014Pathophysiology and therapeutic concepts. Front. Med., 8.","DOI":"10.3389\/fmed.2021.628302"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2213-2600(21)00451-3","article-title":"Extracorporeal haemoadsorption: Does the evidence support its routine use in critical care?","volume":"10","author":"Supady","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Reignier","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","author":"Brower","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the IDSA","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5301\/ijao.5000591","article-title":"Continuous hemoadsorption with a cytokine adsorber (CytoSorb\u00ae) in a septic shock patient: A case report and review of the literature","volume":"40","author":"Houschyar","year":"2017","journal-title":"Int. J. Artif. Organs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-day mortality in endotoxemic septic shock (EUPHRATES Trial)","volume":"320","author":"Dellinger","year":"2018","journal-title":"J. Am. Med. Assoc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/dkw377","article-title":"Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: Systematic review and meta-analysis","volume":"72","author":"Zusman","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock (ADRENAL Trial)","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock (APROCCHSS Trial)","volume":"378","author":"Annane","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017 (EPIC III)","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia","volume":"50","author":"Torres","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1177\/08850666251331905","article-title":"Real-World Outcomes of Hemoadsorption with CytoSorb\u00ae in Patients with Septic Shock: Insights from a Single-Center Study","volume":"40","author":"Berlot","year":"2025","journal-title":"J. Intensive Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.52403\/ijhsr.20231046","article-title":"CytoSorb\u00ae in Combination with CRRT in a Patient Suffering from Septic Shock, Acute Respiratory Distress Syndrome (ARDS) and Acute Kidney Injury (AKI): A Case Report","volume":"13","author":"Sharma","year":"2023","journal-title":"Int. J. Health Sci. Res."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/12\/382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:19:17Z","timestamp":1763986757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/12\/382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["diseases13120382"],"URL":"https:\/\/doi.org\/10.3390\/diseases13120382","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}